Predictive Oncology
News
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled to deliver a virtual presentation and host...\n more…
Predictive Oncology (NASDAQ:POAI) Stock Crosses Below Two Hundred Day Moving Average of $1.73
Ticker Report Shares of Predictive Oncology Inc. (NASDAQ:POAI - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.73 and traded as...\n more…
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
Globe Newswire Study further validates highly reproducible drug response data. Enables AI platform to model and predict patient outcomes on historical samples Global biospecimen market valued at $4.4 billion in...\n more…
HC Wainwright Weighs in on Predictive Oncology Inc.'s FY2024 Earnings (NASDAQ:POAI)
Ticker Report Predictive Oncology Inc. (NASDAQ:POAI - Free Report) - Stock analysts at HC Wainwright issued their FY2024 EPS estimates for shares of Predictive Oncology in a research report issued to clients and...\n more…
Equities Analysts Issue Forecasts for Predictive Oncology Inc.'s FY2024 Earnings (NASDAQ:POAI)
Zolmax Predictive Oncology Inc. (NASDAQ:POAI - Free Report) - Investment analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of Predictive Oncology in a research...\n more…
Predictive Oncology Inc. Forecasted to Post Q3 2024 Earnings of ($0.32) Per Share (NASDAQ:POAI)
Zolmax Predictive Oncology Inc. (NASDAQ:POAI - Free Report) - HC Wainwright issued their Q3 2024 EPS estimates for Predictive Oncology in a report issued on Monday, August 19th. HC Wainwright analyst S...\n more…